Literature DB >> 33819101

Medicaid Expansion Increased Medications For Opioid Use Disorder Among Adults Referred By Criminal Justice Agencies.

Utsha G Khatri1, Benjamin A Howell2, Tyler N A Winkelman3.   

Abstract

Individuals involved with the US criminal justice system have high rates of opioid use disorder (OUD) but face significant barriers to evidence-based treatment. Using 2008-17 data from the Treatment Episode Data Set-Admissions, we examined trends in receipt of medications for OUD among individuals referred by criminal justice agencies and other sources both before and after Medicaid expansion. Individuals referred by criminal justice agencies were less likely to receive medications for OUD than were those referred by other sources during our study period, although this disparity narrowed slightly after Medicaid expansion. Receipt of medications for OUD increased more for individuals referred by criminal justice agencies in states that expanded Medicaid compared with those in states that did not. Medicaid expansion may improve evidence-based treatment for individuals with criminal justice involvement and OUD, although additional policy change outside the health care sector is likely needed to reduce persistent treatment disparities.

Entities:  

Mesh:

Year:  2021        PMID: 33819101      PMCID: PMC8168564          DOI: 10.1377/hlthaff.2020.01251

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  31 in total

1.  The War on Drugs That Wasn't: Wasted Whiteness, "Dirty Doctors," and Race in Media Coverage of Prescription Opioid Misuse.

Authors:  Julie Netherland; Helena B Hansen
Journal:  Cult Med Psychiatry       Date:  2016-12

2.  Incarceration and Health.

Authors:  Michael Massoglia; William Alex Pridemore
Journal:  Annu Rev Sociol       Date:  2015-08

3.  Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.

Authors:  Sarah E Wakeman; Marc R Larochelle; Omid Ameli; Christine E Chaisson; Jeffrey Thomas McPheeters; William H Crown; Francisca Azocar; Darshak M Sanghavi
Journal:  JAMA Netw Open       Date:  2020-02-05

4.  Health Insurance Trends and Access to Behavioral Healthcare Among Justice-Involved Individuals-United States, 2008-2014.

Authors:  Tyler N A Winkelman; Edith C Kieffer; Susan D Goold; Jeffrey D Morenoff; Kristen Cross; John Z Ayanian
Journal:  J Gen Intern Med       Date:  2016-12       Impact factor: 5.128

5.  Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.

Authors:  Noa Krawczyk; Caroline E Picher; Kenneth A Feder; Brendan Saloner
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 6.301

6.  Impact of Medicaid Expansion on Access to Opioid Analgesic Medications and Medication-Assisted Treatment.

Authors:  Alana Sharp; Austin Jones; Jennifer Sherwood; Oksana Kutsa; Brian Honermann; Gregorio Millett
Journal:  Am J Public Health       Date:  2018-03-22       Impact factor: 9.308

7.  Barriers and Facilitators to Treatment Engagement Among Clients in Inpatient Substance Abuse Treatment.

Authors:  Yang Yang; David R Perkins; A Elizabeth Stearns
Journal:  Qual Health Res       Date:  2018-04-21

8.  Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons.

Authors:  Lia N Pizzicato; Rebecca Drake; Reed Domer-Shank; Caroline C Johnson; Kendra M Viner
Journal:  Drug Alcohol Depend       Date:  2018-06-05       Impact factor: 4.492

9.  Specialty Substance Use Disorder Treatment Admissions Steadily Increased In The Four Years After Medicaid Expansion.

Authors:  Brendan Saloner; Johanna Catherine Maclean
Journal:  Health Aff (Millwood)       Date:  2020-03       Impact factor: 6.301

10.  Competing priorities that rival health in adults on probation in Rhode Island: substance use recovery, employment, housing, and food intake.

Authors:  Kimberly R Dong; Aviva Must; Alice M Tang; Curt G Beckwith; Thomas J Stopka
Journal:  BMC Public Health       Date:  2018-02-27       Impact factor: 3.295

View more
  5 in total

1.  Eliminating the buprenorphine DEA X waiver is critical to promote health equity.

Authors:  Katie Fitzgerald Jones; Monica O'Reilly-Jacob; Mathew Tierney
Journal:  Nurs Outlook       Date:  2021-12-08       Impact factor: 3.250

2.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

3.  A longitudinal cross-sectional analysis of substance use treatment trends for individuals experiencing homelessness, criminal justice involvement, both, or neither - United States, 2006-2018.

Authors:  Riley D Shearer; Nathan D Shippee; Kathrine Diaz Vickery; Maria A Stevens; Tyler N A Winkelman
Journal:  Lancet Reg Health Am       Date:  2022-01-06

4.  Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.

Authors:  Natrina L Johnson; Sugy Choi; Carolina-Nicole Herrera
Journal:  J Subst Abuse Treat       Date:  2021-06-11

5.  Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.

Authors:  George Pro; Brooke E E Montgomery; Nickolas Zaller
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.